NCT03279536 (TDI) is a Phase 1, PHASE2 clinical trial of Oral lactoferrin in Iron Deficiency Anemia, sponsored by Woman's Health University Hospital, Egypt.

Who is sponsoring NCT03279536?

NCT03279536 is sponsored by Woman's Health University Hospital, Egypt.

What drugs are being tested in NCT03279536?

Interventions in NCT03279536: Oral lactoferrin, TDI of LMW iron dextran.

What condition does NCT03279536 study?

NCT03279536 studies Iron Deficiency Anemia.

Is NCT03279536 still recruiting?

NCT03279536 is currently completed. Last updated 27 October 2020.

Last reviewed 2020-10-27 · How we verify

NCT03279536: TDI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing

Completed Phase 1, PHASE2 Last updated 27 October 2020

What this trial tests

Phase 1, PHASE2 trial testing Oral lactoferrin in Iron Deficiency Anemia in 99 participants. Completed in 30 December 2018.

Timeline

1 November 2017

Primary endpoint
30 December 2018

30 December 2018

Quick facts

Lead sponsor	Woman's Health University Hospital, Egypt
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	99
Start date	1 November 2017
Primary completion	30 December 2018
Estimated completion	30 December 2018
Sites	1 location across Egypt

Drugs / interventions tested

Oral lactoferrin
TDI of LMW iron dextran

Conditions studied

Iron Deficiency Anemia — all drugs for Iron Deficiency Anemia →

Sponsor

Woman's Health University Hospital, Egypt

Who can join

Adults 18 to 40, female only, with Iron Deficiency Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study consisted of 60 cases. All the cases of pregnant women are 4 months to 8 months of pregnancy. The cases divided into 30 pregnant women's were given iron supplementation without health education and another 30 were given iron supplementation and health education for comparison between them. Comparative between hemoglobin levels before and after medication. Treatment of iron deficiency anemia with iron supplementation received for one month.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of vitamin and mineral supplementation during pregnancy on maternal, birth, child health and development outcomes in low- and middle-income countries: A systematic review.
Keats EC, Oh C, Chau T, Khalifa DS, et al · · 2021 · cited 22× · PMID 37051178 · DOI 10.1002/cl2.1127

Verify or expand the search:

Other recruiting trials for Iron Deficiency Anemia

Currently open trials in the same condition.

NCT07483645 — Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Ane · active not recruiting
NCT06012760 — The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion · NA · recruiting
NCT06742528 — Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients · NA · recruiting
NCT05929729 — Iron Deficiency Anemia (IDA) and the Brain · Phase 4 · recruiting
NCT05985070 — Evaluating the Effectiveness of Various Iron Salts in Oral Iron Therapy for Iron Deficiency and Anemia in Healthy Adults · NA · active not recruiting

Other Woman's Health University Hospital, Egypt trials

Trials by the same sponsor.

NCT05771922 — Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT05734287 — The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Co · recruiting
NCT04357054 — Darwish Hysteroscopic Test (Hysteroscopic Bubble Suction and Tubal Peristalsis of Darwish Triad) in Myomatous Uterus · NA · unknown
NCT04825041 — Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03279536 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Woman's Health University Hospital, Egypt
Last refreshed: 27 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03279536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing